DD02

D&D Pharmatech

Drug Candidate

DD02

Summary

Peptide based, oral GLP-1R agonist for Type 2 Diabetes / NASH

Mechanism of Action

Oral GLP-1R agonist

Indication

Type 2 Diabetes

Development Stage

Drug Discovery